SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Current Assets

Current assets not reported separately, such as prepaid expenses.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Current Assets · Q1 FY2026 · quarter ended Mar 2026

Other current assets of $1.71M in Q1 FY2026

Q1 FY2026 other current assets was $1.71M.

Context

  • Other current assets amounted to 0.7% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.71M— QoQ
Last fiscal yearDec 2025
$0— YoY
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Current Assets vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
  • Other current assets amounts to 0.7% of total assets for SGP, versus a peer median of 1.7%.
SGP Competitors
Other Current Assets for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$533M USD+15.2%+299.2%1.7%
BLCOBausch + Lomb CorporationJun 2026$396M USD-9.0%-0.5%2.9%
GKOSGlaukos CorporationJun 2026$31.35M USD+129.3%+11.7%3.4%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$24.55M USD+1652.5%+195.1%8.5%
OCULOcular Therapeutix, Inc.Mar 2026$11.21M USD+17.7%+39.2%1.5%
RXSTRxSight, Inc.Mar 2026$4.03M USD-11.2%+14.0%1.3%
SGHTSight Sciences, Inc.Mar 2026$3.95M USD+35.7%-1.6%3.6%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$1.71M USD——0.7%
STAASTAAR Surgical CompanyApr 2026$851K USD+192.4%+114.8%0.2%
OCSOculis Holding AGMar 2026CHF 0 CHF—+65.6%0.0%
Peer median (excluding SGP) —+26.7%+39.2%1.7%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.